Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback Medical Dialogues Bureau14 April 2020 3:16 PM ISTDelhi: Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both domestic demands and to meet export...
Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production Medical Dialogues Bureau14 April 2020 2:52 PM ISTThe raw materials which earlier used to cost Rs 9,000 per kilogram are now being sold at Rs 55,000-75,000
Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD Medical Dialogues Bureau14 April 2020 1:45 PM ISTMumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial...
Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital Medical Dialogues Bureau14 April 2020 1:41 PM IST"The funding will allow us to invest further into improving patient outcomes and generate further real-world evidence while expanding our therapeutic...
Top priority on Delivery of Medicines through Speed Post: Minister Medical Dialogues Bureau14 April 2020 1:40 PM ISTDelhi: With the rising cases of coronavirus and the consequent lockdown preventing the movement of people even to take their essential...
Lasa Supergenerics gets FDA nod for Progesterone Medical Dialogues Bureau14 April 2020 9:00 AM ISTMumbai: API producer, Lasa Supergenerics Ltd has forayed into the hormone and steroid API segment for Human application with its approval from the...
Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance Medical Dialogues Bureau13 April 2020 3:48 PM ISTCompanies like Zydus Cadila and IPCA are the major manufacturers of hydroxychloroquine in the country, Jain said
SMS Pharma updates against USFDA statement on Ranitidine Medical Dialogues Bureau13 April 2020 2:31 PM ISTIndia: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the...
Lupin Contributes Rs 21 crores in battle against COVID-19 Medical Dialogues Bureau13 April 2020 1:00 PM ISTMumbai: Lupin Limited has announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin's...
AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1 Medical Dialogues Bureau13 April 2020 12:32 PM ISTKenilworth: AstraZeneca and MSD Inc. has announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo...
Lupin gets USFDA EIR for Nagpur Facility Medical Dialogues Bureau13 April 2020 11:02 AM ISTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after the closure of the U.S. FDA inspection of its...
KKR's Envision Healthcare hires bank to explore debt restructuring: Report Medical Dialogues Bureau13 April 2020 9:00 AM ISTUS: Envision Healthcare Corp, a U.S. provider of physicians and other medical staff owned by buyout firm KKR & Co Inc (KKR.N), has hired a...
